✦ LIBER ✦

Vascular endothelial cell apoptosis by the HMG-CoA reductase inhibitor fluvastatin: a response blocked by glucocorticoids

Book ID: 105723335
Publisher: Springer-Verlag
Year: 2001
Tongue: English
Weight: 464 KB
Volume: 170
Category: Article
ISSN: 1863-4362
DOI: 10.1007/bf03169629

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The anti-apoptotic effects of HMG-CoA re

The anti-apoptotic effects of HMG-CoA reductase inhibitors on vascular endothelial cells is mediated by ASK1 suppression

✍ Keiichiro Kataoka; Shokei Kim-Mitsuyama 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 50 KB

Pravastatin, a HMG-CoA reductase inhibit

Pravastatin, a HMG-CoA reductase inhibitor, blocks the cell cycle progression but not Ca2+ influx induced by IGF-I in FRTL-5 cells

✍ Hisato Tada; Kaoru Takada; Nobuyuki Amino; Kiyoshi Miyai 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 328 KB

3.P.216 Effects of HMG-CoA reductase inh

3.P.216 Effects of HMG-CoA reductase inhibitors (atorvastatin and simvastatin) on the vasoactive pathways mediated by endothelin-1 and nitric oxide in vascular endothelial cells

✍ Lamas, S.; Hernández-Perera, O.; Pérez-Sala, D.; Navarro-Antolín, J.; Sánchez-Pa 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 163 KB

HMG CoA reductase inhibitor suppresses t

HMG CoA reductase inhibitor suppresses the expression of tissue factor and plasminogen activator inhibitor-1 induced by angiotensin II in cultured rat aortic endothelial cells

✍ Yasufumi Kunieda; Katsumi Nakagawa; Hiromi Nishimura; Hisato Kato; Naoki Ukimura 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 341 KB

Lipid-lowering response of the HMG-CoA r

Lipid-lowering response of the HMG-CoA reductase inhibitor fluvastatin is influenced by polymorphisms in the low-density lipoprotein receptor gene in Brazilian patients with primary hypercholesterolemia

✍ Luis A. Salazar; Mario H. Hirata; Éder C.R. Quintão; Rosario D.C. Hirata 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 63 KB 👁 2 views

Although the efficacy of fluvastatin (HMG-CoA reductase inhibitor) in the treatment of primary hypercholesterolemia is well documented, a wide interindividual variation treatment response has been observed. We have studied the possible role of the AvaII (exon 13), HincII (exon 12), and PvuII (intron

Suppression of neointimal thickening by

Suppression of neointimal thickening by a newly developed HMG-CoA reductase inhibitor, BAYw6228, and its inhibitory effect on vascular smooth muscle cell growth

✍ Masahiko Igarashi; Yuki Takeda; Seijiro Mori; Naoko Ishibashi; Eiichi Komatsu; K 📂 Article 📅 1997 🏛 Nature Publishing Group 🌐 English ⚖ 661 KB